Profile data is unavailable for this security.
About the company
ZhuZhou QianJin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of Chinese patent medicines, chemical drugs and feminine hygiene products. The Company is also engaged in the wholesale and retail business of pharmaceuticals. The Company's main products include Gynecological Qianjin Tablets, Buxue Yimu Pills, Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin methanolamine Tablets, amlodipine besylate Tablets, finasteride Tablets, and a series of gynecological cotton towels, and others. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)3.63bn
- Net income in CNY250.04m
- Incorporated1993
- Employees5.27k
- LocationZhuZhou QianJin Pharmaceutical Co LtdNo.801 Zhuzhou Avenue, Tianyuan DistrictZHUZHOU 412007ChinaCHN
- Phone+86 73 122496088
- Fax+86 73 122496088
- Websitehttps://www.qjyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.68bn | 295.36m | 5.30bn | 1.81k | 17.99 | 3.17 | -- | 3.15 | 0.6709 | 0.6709 | 3.83 | 3.81 | 0.5327 | 1.42 | 6.00 | 931,293.10 | 9.11 | 6.11 | 16.09 | 10.86 | 68.68 | 67.05 | 17.10 | 10.32 | 0.5475 | 19.04 | 0.2332 | 49.73 | 9.15 | 10.20 | 36.61 | 26.46 | -13.82 | 38.88 |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.63bn | 250.04m | 5.53bn | 5.27k | 18.38 | 1.88 | -- | 1.52 | 0.6115 | 0.6115 | 8.87 | 5.98 | 0.7768 | 4.12 | 9.84 | 689,467.60 | 7.43 | 8.36 | 13.56 | 15.33 | 48.13 | 44.74 | 9.56 | 9.71 | 1.13 | -- | 0.0182 | 67.36 | -4.44 | 0.5863 | -27.98 | -4.75 | 3.10 | -6.36 |
| Hunan Warrant Pharmaceutical Co Ltd | 1.43bn | 213.03m | 5.63bn | 1.24k | 26.42 | 2.83 | -- | 3.94 | 1.62 | 1.62 | 10.89 | 15.17 | 0.554 | 1.40 | 7.99 | 1,154,661.00 | 7.61 | 9.47 | 8.79 | 11.61 | 59.10 | 67.03 | 13.74 | 13.01 | 3.03 | -- | 0.1503 | 14.11 | -1.38 | 11.37 | -22.24 | 7.21 | 57.23 | -- |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 957.76m | 241.67m | 5.70bn | 1.33k | 23.63 | 2.42 | -- | 5.95 | 1.21 | 1.21 | 4.79 | 11.82 | 0.3733 | 3.26 | 3.71 | 721,747.90 | 9.37 | 8.99 | 10.04 | 9.78 | 87.92 | 88.72 | 25.11 | 23.97 | 7.17 | -- | 0.0092 | 32.97 | 4.14 | 10.57 | 0.1095 | 14.20 | 42.01 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.60bn | -43.60m | 5.80bn | 1.39k | -- | 4.34 | -- | 2.23 | -0.1527 | -0.1527 | 9.10 | 4.68 | 0.7279 | 3.28 | 4.16 | 1,872,001.00 | -0.8081 | 5.51 | -1.74 | 10.75 | 36.36 | 51.36 | -1.11 | 7.34 | 0.7909 | 1.88 | 0.4592 | 30.61 | -0.6275 | 10.86 | -37.66 | 1.09 | 1.85 | 1.16 |
Data as of Mar 03 2026. Currency figures normalised to ZhuZhou QianJin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 2.60m | 0.62% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.56m | 0.37% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 730.00k | 0.17% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 677.10k | 0.16% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 625.90k | 0.15% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 619.70k | 0.15% |
| The Vanguard Group, Inc.as of 31 Jan 2026 | 406.72k | 0.10% |
| Goldstate Capital Fund Management Co., Ltd.as of 30 Jun 2025 | 362.92k | 0.09% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 259.80k | 0.06% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 247.10k | 0.06% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
